Chemoinformaics analysis of 5-(ethoxymethyl)furan-2-carbaldehyde
| Molecular Weight | 154.165 | nRot | 4 |
| Heavy Atom Molecular Weight | 144.085 | nRig | 6 |
| Exact Molecular Weight | 154.063 | nRing | 1 |
| Solubility: LogS | -1.16 | nHRing | 1 |
| Solubility: LogP | 0.963 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 5 |
| nHA | 3 | APOL | 22.4339 |
| nHD | 0 | BPOL | 14.3721 |
| QED | 0.619 |
| Synth | 2.4 |
| Natural Product Likeliness | -0.378 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.352 |
| HIA | 0.005 |
| CACO-2 | -4.555 |
| MDCK | 0.0000236 |
| BBB | 0.976 |
| PPB | 0.669163 |
| VDSS | 1.357 |
| FU | 0.54216 |
| CYP1A2-inh | 0.734 |
| CYP1A2-sub | 0.624 |
| CYP2c19-inh | 0.12 |
| CYP2c19-sub | 0.225 |
| CYP2c9-inh | 0.022 |
| CYP2c9-sub | 0.138 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.462 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.27 |
| CL | 6.663 |
| T12 | 0.768 |
| hERG | 0.058 |
| Ames | 0.906 |
| ROA | 0.079 |
| SkinSen | 0.202 |
| Carcinogencity | 0.907 |
| EI | 0.967 |
| Respiratory | 0.071 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.91833 |